| Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664) |
|---|
| 02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 02/20/2007 | US7179817 For therapy and prophylaxis of peripheral arterial disease such as arteriosclerosis obliterans, thromboangiitis obliterans, Buerger's disease or diabetic neuropathy, sepsis, angiitis, nephritis, pneumonia, stroke, myocardial infarction, edematous state, atherosclerosis, varicosity such as hemorrhoid |
| 02/15/2007 | WO2007017267A2 Novel compounds |
| 02/15/2007 | WO2007017093A1 Substituted 2-benzyloxy-benzoic acid amide derivatives |
| 02/15/2007 | WO2005092897A3 2,4,6-phenylsubstituted cyclic ketoenoles |
| 02/15/2007 | US20070037864 Intermediates for the preparation of lipoxin A4 analogs |
| 02/15/2007 | US20070037785 Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases |
| 02/14/2007 | EP1751097A1 Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies |
| 02/14/2007 | EP1751091A2 2-amino- and 2-thio-substituted 1,3-diaminopropanes |
| 02/14/2007 | EP1751090A1 Acid derivatives of substituted cyclohexyl-1,4-diamines |
| 02/14/2007 | EP1751088A1 Oxo-substituted cyclohexyl-1,4-diamine derivatives |
| 02/14/2007 | EP1751087A1 Levodopa prodrugs, and compositions and uses thereof |
| 02/14/2007 | EP1750721A1 Topical cromolyn formulations |
| 02/14/2007 | EP1750694A2 Metabolites of selective androgen receptor modulators and methods of use thereof |
| 02/14/2007 | EP1750691A2 Compounds for treatment of aids and other diseases |
| 02/14/2007 | EP1395586B1 Method for the production of zolpidem |
| 02/14/2007 | EP1126836B1 Benzamide potassium channel inhibitors |
| 02/14/2007 | CN1914152A New compounds, methods for their preparation and use thereof |
| 02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 02/13/2007 | CA2285037C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 02/08/2007 | WO2007014843A1 2-hydroxy-propionic acid derivatives and 3-hydroxy-benzofuran-2-one derivatives with affinity for the gaba-b-receptor |
| 02/08/2007 | US20070032532 Hsp90 family protein inhibitors |
| 02/08/2007 | CA2616685A1 2-hydroxy-propionic acid derivatives and 3-hydroxy-benzofuran-2-one derivatives with affinity for the gaba-b-receptor |
| 02/07/2007 | EP1749870A1 Fluorescein-based compounds and their use for peptide synthesis |
| 02/07/2007 | EP1749522A2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 02/07/2007 | EP1017680B1 Tricyclic compounds, preparation method and said method intermediates, application as medicines and pharmaceutical compositions containing same |
| 02/07/2007 | CN1910135A Amino alcohol derivatives and their activity as renin inhibitors |
| 02/07/2007 | CN1298706C Insecticidal diamides |
| 02/07/2007 | CN1298700C Pseudo-nervonic amide and cosmetics composition containing the same |
| 02/06/2007 | CA2192594C Preparation of .alpha.-methoxyiminocarboxylic acid methylamides and intermediates therfore |
| 02/03/2007 | CA2555115A1 New crystalline form v of agomelatine, process for its preparation and pharmaceutical compositions containing it |
| 02/01/2007 | WO2007013816A1 Continuous crystallisation process of iodinated phenyl derivatives |
| 02/01/2007 | WO2006138508A3 Benzamide derivatives and uses related thereto |
| 02/01/2007 | WO2006127871A3 Cycloalkylidene compounds as selective estrogen receptor modulators |
| 02/01/2007 | WO2006002802A8 Phenyl derivatives comprising an acetylene group |
| 02/01/2007 | US20070027158 High affinity small molecule C5a receptor modulators |
| 01/31/2007 | EP1747191A1 Substituted cyclohexyl-1,4-diamine derivatives with a chain extension |
| 01/31/2007 | CN1297543C Substitued arylketones |
| 01/30/2007 | US7169776 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 01/30/2007 | US7169523 Charge controllers |
| 01/30/2007 | CA2228939C Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same |
| 01/25/2007 | WO2007010350A1 Synthesis of therapeutic diphenyl ethers |
| 01/25/2007 | US20070021634 Synthesis of therapeutic diphenyl ethers |
| 01/25/2007 | US20070021473 Novel ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof |
| 01/25/2007 | US20070021464 Methods and compositions for inhibition of angiogenesis with EM-12 Derivatives |
| 01/25/2007 | US20070021427 Novel tricyclic derivatives and their use |
| 01/24/2007 | EP1745800A1 Novel blt2-mediated disease, and blt2 binding agent and compound |
| 01/24/2007 | EP1745011A2 Modulators of cannabinoid receptors |
| 01/24/2007 | EP1744742A2 Crystalline and amorphous forms of efaproxiral sodium |
| 01/24/2007 | EP1549609B1 Propargylether derivatives, a process for their preparation and their use for controlling phytopathogenic microorganisms |
| 01/24/2007 | CN1902171A Benzylether amine compounds useful as CCR-5 antagonists |
| 01/24/2007 | CN1900075A Tetrahydro-proto-berberine compounds, their preparing method, composition and use |
| 01/24/2007 | CN1296346C Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 01/23/2007 | US7166746 Fungicides for controlling and preventing an infestation of crop plants by phytopathogenic microorganisms; 2-hydroxy-N-[trans-2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-cyclohexyl]-2-phenyl-acetamide |
| 01/23/2007 | US7166745 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 01/23/2007 | US7166744 Retinoid derivatives and methods for producing said compounds and anti-cancer pharmaceutical composition comprising said compounds |
| 01/23/2007 | US7166743 Methods of making intermediates from polyhydroxyalkanoates |
| 01/23/2007 | US7166606 Certain 1-(D-cycloproplyglycinyl)-4-piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor Xa |
| 01/23/2007 | US7166593 Glucocorticoid receptor modulators |
| 01/23/2007 | US7166590 Antiischemic agents; cardiovascular disorders |
| 01/18/2007 | WO2007007633A1 Process for producing catalyst for cyanhydrin hydration and product of the process |
| 01/18/2007 | WO2007006700A1 Modified poly(propylene-imine) dendrimers and their use as transfection agents for anionic bioactive factors |
| 01/18/2007 | CA2614930A1 Glutamate aggrecanase inhibitors |
| 01/18/2007 | CA2612211A1 Modified poly(propylene-imine) dendrimers and their use as transfection agents for anionic bioactive factors |
| 01/17/2007 | EP1743632A1 Novel 4-dedimethy laminotetracycline derivatives |
| 01/17/2007 | EP1742908A1 Non-nucleoside reverse transcriptase inhibitors |
| 01/17/2007 | EP1742907A2 Certain chemical entities, compositions, and methods |
| 01/17/2007 | CN1898198A Alpha-hydroxy amides as bradykinin antagonists or inverse agonists |
| 01/17/2007 | CN1896070A 2- and 2,5-substituted phenylketo-enols |
| 01/17/2007 | CN1896045A Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar) |
| 01/16/2007 | US7164036 Colorant dispersibility, image lightfastness; storage stability |
| 01/16/2007 | US7163958 Compositions comprising nitrosated NSAID and compound that donates, transfers or releases nitric oxide, or stimulates endogenous synthesis of nitric oxide; treatment of inflammation, pain, fever, gastrointestinal disorders |
| 01/16/2007 | CA2208746C Novel immunotherapeutic aryl amides |
| 01/11/2007 | WO2007005991A1 Inhibitors of fibroblast activation protein alpha |
| 01/11/2007 | WO2007004957A1 Novel crystalline form |
| 01/11/2007 | WO2006117669B1 Amide resorcinol compounds |
| 01/11/2007 | WO2006084369A9 Diamine calcium channel blockers |
| 01/11/2007 | US20070010579 Copper salts of organic acids and use thereof as fungicides |
| 01/11/2007 | US20070010558 Opioid receptor antagonists |
| 01/11/2007 | US20070010422 Improved bioavailability; for oral and intracolonic administration |
| 01/11/2007 | CA2613795A1 Inhibitors of fibroblast activation protein alpha |
| 01/10/2007 | EP1740540A1 Phenyl acetamides |
| 01/10/2007 | EP1740530A2 Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders |
| 01/10/2007 | EP1740522A2 Bisphenyl compounds useful as vitamin d sb 3 /sb receptor agonists |
| 01/09/2007 | US7161042 Protected diols for prostaglandin synthesis |
| 01/09/2007 | US7161022 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative |
| 01/09/2007 | US7160923 Polyamine analogues as therapeutic and diagnostic agents |
| 01/09/2007 | US7160874 Phenylalanine derivatives |
| 01/09/2007 | CA2308520C Strictly alternating poly(alkylene oxide ether) copolymers |
| 01/04/2007 | WO2005015158A3 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
| 01/03/2007 | EP1737925A1 New organic luminescent element |
| 01/03/2007 | EP1737827A1 Process for preparing pyridazinone compounds |
| 01/03/2007 | EP1439843A4 Tetracycline derivatives and methods of use thereof |
| 01/03/2007 | CN1890208A Opioid receptor antagonists |
| 01/03/2007 | CN1889960A Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases |
| 01/03/2007 | CN1293044C Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (PPAR) |
| 01/02/2007 | US7157423 Using fumaric acid mono- and diamides, or monoamido fumaric acid monoesters for therapy of an autoimmune disease; transplantation medicine; therapy of mitochondrial diseases, for therapy of NF-kappaB mediated diseases |
| 01/02/2007 | US7157092 3-(3-dodecanoyloxytetradecanoylamino) 9-(3-hydroxytetradecanoylamino)-4-oxo-5-azadecan-1,10-diol, 1,10-bis-(dihydrogenphosphate) or its addition salts; treatment of diseases related to a deficiency in the immune defense system or an overexpression of immune responses, cancer therapy |
| 01/02/2007 | CA2235996C New compounds and their compositions having anti-inflammatory and anti-thrombotic activities |
| 12/28/2006 | WO2006138673A2 Synthetic processes for the preparation of aminocyclohexyl ether compounds |